These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15501481)

  • 1. Irsogladine, an anti-ulcer drug, suppresses superoxide production by inhibiting phosphodiesterase type 4 in human neutrophils.
    Kyoi T; Noda K; Oka M; Ukai Y
    Life Sci; 2004 Nov; 76(1):71-83. PubMed ID: 15501481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphodiesterase inhibition by a gastroprotective agent irsogladine: preferential blockade of cAMP hydrolysis.
    Kyoi T; Oka M; Noda K; Ukai Y
    Life Sci; 2004 Aug; 75(15):1833-42. PubMed ID: 15302227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of PDE4 in superoxide anion generation through p44/42MAPK regulation: a cAMP and a PKA-independent mechanism.
    Jacob C; Szilagyi C; Allen JM; Bertrand C; Lagente V
    Br J Pharmacol; 2004 Sep; 143(2):257-68. PubMed ID: 15313882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphodiesterase type IV inhibitors prevent ischemia-reperfusion-induced gastric injury in rats.
    Kyoi T; Kitazawa S; Tajima K; Zhang X; Ukai Y
    J Pharmacol Sci; 2004 Jul; 95(3):321-8. PubMed ID: 15272207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irsogladine maleate potentiates the effects of nitric oxide on activation of cAMP signalling pathways and suppression of mesangial cell mitogenesis.
    Yao J; Zhu Y; Sun W; Sawada N; Hiramatsu N; Takeda M; Kitamura M
    Br J Pharmacol; 2007 Jun; 151(4):457-66. PubMed ID: 17435794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of PDE4 inhibitors on zymosan-induced IL-8 release from human neutrophils: synergism with prostanoids and salbutamol.
    Au BT; Teixeira MM; Collins PD; Williams TJ
    Br J Pharmacol; 1998 Mar; 123(6):1260-6. PubMed ID: 9559913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of non-selective and selective phosphodiesterase inhibitors on human eosinophil functions.
    Hatzelmann A; Tenor H; Schudt C
    Br J Pharmacol; 1995 Feb; 114(4):821-31. PubMed ID: 7539697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of SCA40 on human isolated bronchus and human polymorphonuclear leukocytes: comparison with rolipram, SKF94120 and levcromakalim.
    Cortijo J; Villagrasa V; Navarrete C; Sanz C; Berto L; Michel A; Bonnet PA; Morcillo EJ
    Br J Pharmacol; 1996 Sep; 119(1):99-106. PubMed ID: 8872362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of superoxide anion and elastase release in human neutrophils by 3'-isopropoxychalcone via a cAMP-dependent pathway.
    Hwang TL; Yeh SH; Leu YL; Chern CY; Hsu HC
    Br J Pharmacol; 2006 May; 148(1):78-87. PubMed ID: 16501579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DSM-RX78, a new phosphodiesterase inhibitor, suppresses superoxide anion production in activated human neutrophils and attenuates hemorrhagic shock-induced lung injury in rats.
    Yu HP; Hsieh PW; Chang YJ; Chung PJ; Kuo LM; Hwang TL
    Biochem Pharmacol; 2009 Oct; 78(8):983-92. PubMed ID: 19540209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the cyclic nucleotide phosphodiesterase subtypes involved in the regulation of the L-type Ca2+ current in rat ventricular myocytes.
    Verde I; Vandecasteele G; Lezoualc'h F; Fischmeister R
    Br J Pharmacol; 1999 May; 127(1):65-74. PubMed ID: 10369457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of selective and non-selective phosphodiesterase inhibitors on allergen- and leukotriene C(4)-induced contractions in passively sensitized human airways.
    Schmidt DT; Watson N; Dent G; Rühlmann E; Branscheid D; Magnussen H; Rabe KF
    Br J Pharmacol; 2000 Dec; 131(8):1607-18. PubMed ID: 11139438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphodiesterase (PDE) 7 in inflammatory cells from patients with asthma and COPD.
    Jones NA; Leport M; Holand T; Vos T; Morgan M; Fink M; Pruniaux MP; Berthelier C; O'Connor BJ; Bertrand C; Page CP
    Pulm Pharmacol Ther; 2007; 20(1):60-8. PubMed ID: 16427796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irsogladine maleate suppresses indomethacin-induced elevation of proinflammatory cytokines and gastric injury in rats.
    Zhang X; Tajima K; Kageyama K; Kyoi T
    World J Gastroenterol; 2008 Aug; 14(30):4784-90. PubMed ID: 18720540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential inhibition of human neutrophil functions. Role of cyclic AMP-specific, cyclic GMP-insensitive phosphodiesterase.
    Wright CD; Kuipers PJ; Kobylarz-Singer D; Devall LJ; Klinkefus BA; Weishaar RE
    Biochem Pharmacol; 1990 Aug; 40(4):699-707. PubMed ID: 1696820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P; Prigent AF; Lagarde M; Nemoz G
    Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PDE4 and PDE5 regulate cyclic nucleotides relaxing effects in human umbilical arteries.
    Santos-Silva AJ; Cairrão E; Morgado M; Alvarez E; Verde I
    Eur J Pharmacol; 2008 Mar; 582(1-3):102-9. PubMed ID: 18234184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphodiesterase isozymes involved in regulating acid secretion in the isolated mouse stomach.
    Okuda S; Honda M; Ito Y; Aihara E; Kato S; Mitsufuji S; Yoshikawa T; Takeuchi K
    J Physiol Pharmacol; 2009 Dec; 60 Suppl 7():183-90. PubMed ID: 20388963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of specific phosphodiesterase isoenzyme inhibitors on bovine oocyte meiotic maturation.
    Thomas RE; Armstrong DT; Gilchrist RB
    Dev Biol; 2002 Apr; 244(2):215-25. PubMed ID: 11944932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of neutrophilic inflammation inhibitors.
    Bruno O; Brullo C; Arduino N; Schenone S; Ranise A; Bondavalli F; Ottonello L; Dapino P; Dallegri F
    Farmaco; 2004 Mar; 59(3):223-35. PubMed ID: 14987986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.